20. ** ^  ** Streptomycin in Tuberculosis Trials Committee (October 1948).  "STREPTOMYCIN treatment of pulmonary tuberculosis"  . _British Medical Journal_ . **2** (4582): 769–782.  doi  "Doi \(identifier\)") :  10.1136/bmj.2.4582.769  .  PMC  "PMC \(identifier\)")  2091872  .  PMID  "PMID \(identifier\)")  18890300  .
21. ** ^  ** Brown D (1998-11-02). "Landmark study made research resistant to bias". _ Washington Post  _ .
22. ** ^  ** Shikata S, Nakayama T, Noguchi Y, et al. (November 2006).  "Comparison of effects in randomized controlled trials with observational studies in digestive surgery"  . _Annals of Surgery_ . **244** (5): 668–676.  doi  "Doi \(identifier\)") :  10.1097/01.sla.0000225356.04304.bc  .  PMC  "PMC \(identifier\)")  1856609  .  PMID  "PMID \(identifier\)")  17060757  .
23. ^  _**a** _ _**b** _ Stolberg HO, Norman G, Trop I (December 2004). "Randomized controlled trials". _AJR. American Journal of Roentgenology_ . **183** (6): 1539–1544.  doi  "Doi \(identifier\)") :  10.2214/ajr.183.6.01831539  .  PMID  "PMID \(identifier\)")  15547188  .  S2CID  "S2CID \(identifier\)")  5376391  .
24. ** ^  ** Ferry G (2 November 2020).  "Peter Sleight Obituary"  . _The Guardian_ . Retrieved  3 November  2020  .
25. ** ^  ** Meldrum ML (August 2000).  "A brief history of the randomized controlled trial. From oranges and lemons to the gold standard"  . _Hematology/Oncology Clinics of North America_ . **14** (4): 745–60, vii.  doi  "Doi \(identifier\)") :  10.1016/S0889-8588(05)70309-9  .  PMID  "PMID \(identifier\)")  10949771  .
26. ** ^  ** Freedman B (July 1987). "Equipoise and the ethics of clinical research". _The New England Journal of Medicine_ . **317** (3): 141–145.  doi  "Doi \(identifier\)") :  10.1056/NEJM198707163170304  .  PMID  "PMID \(identifier\)")  3600702  .
27. ** ^  ** Gifford F (April 1995). "Community-equipoise and the ethics of randomized clinical trials". _Bioethics_ . **9** (2): 127–148.  doi  "Doi \(identifier\)") :  10.1111/j.1467-8519.1995.tb00306.x  .  PMID  "PMID \(identifier\)")  11653056  .
28. ** ^  ** Edwards SJ, Lilford RJ, Hewison J (October 1998).  "The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals"  . _BMJ_ . **317** (7167): 1209–1212.  doi  "Doi \(identifier\)") :  10.1136/bmj.317.7167.1209  .  PMC  "PMC \(identifier\)")  1114158  .  PMID  "PMID \(identifier\)")  9794861  .
29. ** ^  ** Zelen M (May 1979). "A new design for randomized clinical trials". _The New England Journal of Medicine_ . **300** (22): 1242–1245.  doi  "Doi \(identifier\)") :  10.1056/NEJM197905313002203  .  PMID  "PMID \(identifier\)")  431682  .
30. ** ^  ** Torgerson DJ, Roland M (February 1998).  "What is Zelen's design?"  . _BMJ_ . **316** (7131): 606.  doi  "Doi \(identifier\)") :  10.1136/bmj.316.7131.606  .  PMC  "PMC \(identifier\)")  1112637  .  PMID  "PMID \(identifier\)")  9518917  .
31. ** ^  ** Appelbaum PS, Roth LH, Lidz C (1982). "The therapeutic misconception: informed consent in psychiatric research". _International Journal of Law and Psychiatry_ . **5** (3–4): 319–329.  doi  "Doi \(identifier\)") :  10.1016/0160-2527(82)90026-7  .  PMID  "PMID \(identifier\)")  6135666  .
32. ^  _**a** _ _**b** _ Henderson GE, Churchill LR, Davis AM, et al. (November 2007).  "Clinical trials and medical care: defining the therapeutic misconception"  . _PLOS Medicine_ . **4** (11): e324.  doi  "Doi \(identifier\)") :   10.1371/journal.pmed.0040324  .  PMC  "PMC \(identifier\)")  2082641  .  PMID  "PMID \(identifier\)")  18044980  .
33. ** ^  ** Jain SL (2010).  "The mortality effect: counting the dead in the cancer trial"  (PDF)  . _ Public Culture  _ . **21** (1): 89–117.  doi  "Doi \(identifier\)") :  10.1215/08992363-2009-017  .  S2CID  "S2CID \(identifier\)")  143641293  . Archived from  the original  (PDF)  on 2020-02-20.
34. ** ^  ** De Angelis C, Drazen JM, Frizelle FA, et al. (September 2004).  "Clinical trial registration: a statement from the International Committee of Medical Journal Editors"  . _The New England Journal of Medicine_ . **351** (12): 1250–1251.  doi  "Doi \(identifier\)") :   10.1056/NEJMe048225  .  PMID  "PMID \(identifier\)")  15356289  .
35. ** ^  ** Law MR, Kawasumi Y, Morgan SG (December 2011).  "Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov"  . _Health Affairs_ . **30** (12): 2338–2345.  doi  "Doi \(identifier\)") :   10.1377/hlthaff.2011.0172  .  PMID  "PMID \(identifier\)")  22147862  .
36. ** ^  ** Mathieu S, Boutron I, Moher D, et al. (September 2009).  "Comparison of registered and published primary outcomes in randomized controlled trials"  . _JAMA_ . **302** (9): 977–984.  doi  "Doi \(identifier\)") :   10.1001/jama.2009.1242  .  PMID  "PMID \(identifier\)")  19724045  .
37. ** ^  ** Bhaumik S, Biswas T (March 2013). "Editorial policies of MEDLINE indexed Indian journals on clinical trial registration". _Indian Pediatrics_ . **50** (3): 339–340.  doi  "Doi \(identifier\)") :  10.1007/s13312-013-0092-2  .  PMID  "PMID \(identifier\)")  23680610  .  S2CID  "S2CID \(identifier\)")  40317464  .
38. ^  _**a** _ _**b** _ Hopewell S, Dutton S, Yu LM, et al. (March 2010).  "The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed"  . _BMJ_ . **340** : c723.  doi  "Doi \(identifier\)") :  10.1136/bmj.c723  .  PMC  "PMC \(identifier\)")  2844941  .  PMID  "PMID \(identifier\)")  20332510  .
39. ** ^  ** Kaiser J, Niesen W, Probst P, et al. (June 2019).  "Abdominal drainage versus no drainage after distal pancreatectomy: study protocol for a randomized controlled trial"  . _Trials_ . **20** (1): 332.  doi  "Doi \(identifier\)") :   10.1186/s13063-019-3442-0  .  PMC  "PMC \(identifier\)")  6555976  .  PMID  "PMID \(identifier\)")  31174583  .
40. ** ^  ** Farag SM, Mohammed MO, El-Sobky TA, et al. (March 2020).  "Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials"  . _JBJS Reviews_ . **8** (3): e0119.  doi  "Doi \(identifier\)") :   10.2106/JBJS.RVW.19.00119  .  PMC  "PMC \(identifier\)")  7161716  .  PMID  "PMID \(identifier\)")  32224633  .
41. ** ^  ** Jones B, Kenward MG (2003). _Design and Analysis of Cross-Over Trials_ (Second ed.). London: Chapman and Hall.
42. ** ^  ** Vonesh EF, Chinchilli VG (1997). "Crossover Experiments". _Linear and Nonlinear Models for the Analysis of Repeated Measurements_ . London: Chapman and Hall. pp. 111–202.
43. ** ^  ** Gall S, Adams L, Joubert N, et al. (8 November 2018).  "Effect of a 20-week physical activity intervention on selective attention and academic performance in children living in disadvantaged neighborhoods: A cluster randomized control trial"  . _PLOS ONE_ . **13** (11): e0206908.  Bibcode  "Bibcode \(identifier\)") :  2018PLoSO..1306908G  .  doi  "Doi \(identifier\)") :   10.1371/journal.pone.0206908  .  PMC  "PMC \(identifier\)")  6224098  .  PMID  "PMID \(identifier\)")  30408073  .
44. ** ^  ** Gladstone MJ, Chandna J, Kandawasvika G, et al. (March 2019).  "Independent and combined effects of improved water, sanitation, and hygiene (WASH) and improved complementary feeding on early neurodevelopment among children born to HIV-negative mothers in rural Zimbabwe: Substudy of a cluster-randomized trial"  . _PLOS Medicine_ . **16** (3): e1002766.  doi  "Doi \(identifier\)") :   10.1371/journal.pmed.1002766  .  PMC  "PMC \(identifier\)")  6428259  .  PMID  "PMID \(identifier\)")  30897095  .
45. ^  _**a** _ _**b** _ _**c** _ _**d** _ Zwarenstein M, Treweek S, Gagnier JJ, et al. (November 2008).  "Improving the reporting of pragmatic trials: an extension of the CONSORT statement"  . _BMJ_ . **337** : a2390.  doi  "Doi \(identifier\)") :  10.1136/bmj.a2390  .  PMC  "PMC \(identifier\)")  3266844  .  PMID  "PMID \(identifier\)")  19001484  .
46. ^  _**a** _ _**b** _ _**c** _ _**d** _ Piaggio G, Elbourne DR, Altman DG, et al. (March 2006).  "Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement"  (PDF)  . _JAMA_ . **295** (10): 1152–1160.  doi  "Doi \(identifier\)") :  10.1001/jama.295.10.1152  .  PMID  "PMID \(identifier\)")  16522836  .
47. ^  _**a** _ _**b** _ _**c** _ Schulz KF, Grimes DA (February 2002). "Generation of allocation sequences in randomised trials: chance, not choice". _Lancet_ . **359** (9305): 515–519.  doi  "Doi \(identifier\)") :  10.1016/S0140-6736(02)07683-3  .  PMID  "PMID \(identifier\)")  11853818  .  S2CID  "S2CID \(identifier\)")  291300  .  [ _ dead link   _ ]
48. ^  _**a** _ _**b** _ _**c** _ _**d** _ _**e** _ _**f** _ _**g** _ _**h** _ Schulz KF, Grimes DA (February 2002).  "Allocation concealment in randomised trials: defending against deciphering"  (PDF)  . _Lancet_ . **359** (9306): 614–618.  doi  "Doi \(identifier\)") :  10.1016/S0140-6736(02)07750-4  .  PMID  "PMID \(identifier\)")  11867132  .  S2CID  "S2CID \(identifier\)")  12902486  . Archived from  the original  (PDF)  on September 11, 2012.
49. ** ^  ** Howick J, Mebius A (December 2014).  "In search of justification for the unpredictability paradox"  . _Trials_ . **15** : 480.  doi  "Doi \(identifier\)") :   10.1186/1745-6215-15-480  .  PMC  "PMC \(identifier\)")  4295227  .  PMID  "PMID \(identifier\)")  25490908  .
50. ^  _**a** _ _**b** _ Lachin JM (December 1988). "Statistical properties of randomization in clinical trials". _Controlled Clinical Trials_ . **9** (4): 289–311.  doi  "Doi \(identifier\)") :  10.1016/0197-2456(88)90045-1  .  PMID  "PMID \(identifier\)")  3060315  .
51. ** ^  ** Rosenberger J.  "STAT 503 - Design of Experiments"  . Pennsylvania State University  . Retrieved  24 September  2012  .
52. ** ^  ** Avins AL (December 1998).  "Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials"  . _Journal of Medical Ethics_ . **24** (6): 401–408.  doi  "Doi \(identifier\)") :  10.1136/jme.24.6.401  .  PMC  "PMC \(identifier\)")  479141  .  PMID  "PMID \(identifier\)")  9873981  .
53. ** ^  ** Buyse ME (December 1989). "Analysis of clinical trial outcomes: some comments on subgroup analyses". _Controlled Clinical Trials_ . **10** (4 Suppl): 187S–194S.  doi  "Doi \(identifier\)") :  10.1016/0197-2456(89)90057-3  .  PMID  "PMID \(identifier\)")  2605967  .
54. ^  _**a** _ _**b** _ _**c** _ _**d** _ _**e** _ _**f** _ Lachin JM, Matts JP, Wei LJ (December 1988). "Randomization in clinical trials: conclusions and recommendations". _Controlled Clinical Trials_ . **9** (4): 365–374.  doi  "Doi \(identifier\)") :  10.1016/0197-2456(88)90049-9  .  hdl  "Hdl \(identifier\)") :   2027.42/27041  .  PMID  "PMID \(identifier\)")  3203526  .
55. ** ^  ** Rosenberger WF, Lachin JM (December 1993). "The use of response-adaptive designs in clinical trials". _Controlled Clinical Trials_ . **14** (6): 471–484.  doi  "Doi \(identifier\)") :  10.1016/0197-2456(93)90028-C  .  PMID  "PMID \(identifier\)")  8119063  .
56. ** ^  ** Forder PM, Gebski VJ, Keech AC (January 2005). "Allocation concealment and blinding: when ignorance is bliss". _The Medical Journal of Australia_ . **182** (2): 87–89.  doi  "Doi \(identifier\)") :  10.5694/j.1326-5377.2005.tb06584.x  .  PMID  "PMID \(identifier\)")  15651970  .  S2CID  "S2CID \(identifier\)")  202149  .
57. ** ^  ** Pildal J, Chan AW, Hróbjartsson A, et al. (May 2005).  "Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study"  . _BMJ_ . **330** (7499): 1049.  doi  "Doi \(identifier\)") :  10.1136/bmj.38414.422650.8F  .  PMC  "PMC \(identifier\)")  557221  .  PMID  "PMID \(identifier\)")  15817527  .
58. ^  _**a** _ _**b** _ _**c** _ Wood L, Egger M, Gluud LL, et al. (March 2008).  "Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study"  . _BMJ_ . **336** (7644): 601–605.  doi  "Doi \(identifier\)") :  10.1136/bmj.39465.451748.AD  .  PMC  "PMC \(identifier\)")  2267990  .  PMID  "PMID \(identifier\)")  18316340  .
59. ** ^  ** Glennerster R, Kudzai T (2013). "  "Chapter 6"  ".  _Running randomized evaluations: a practical guide_  . Princeton: Princeton University Press.  doi  "Doi \(identifier\)") :  10.2307/j.ctt4cgd52  .  ISBN  "ISBN \(identifier\)")  9780691159249   .  JSTOR  "JSTOR \(identifier\)")  j.ctt4cgd52  .
60. ** ^  ** Devereaux PJ, Manns BJ, Ghali WA, et al. (April 2001).  "Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials"  . _JAMA_ . **285** (15): 2000–2003.  doi  "Doi \(identifier\)") :   10.1001/jama.285.15.2000  .  PMID  "PMID \(identifier\)")  11308438  .
61. ** ^  ** Haahr MT, Hróbjartsson A (2006). "Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors". _Clinical Trials_ . **3** (4): 360–365.  doi  "Doi \(identifier\)") :  10.1177/1740774506069153  .  PMID  "PMID \(identifier\)")  17060210  .  S2CID  "S2CID \(identifier\)")  23818514  .
62. ** ^  ** Marson AG, Al-Kharusi AM, Alwaidh M, et al. (March 2007).  "The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial"  . _Lancet_ . **369** (9566): 1016–1026.  doi  "Doi \(identifier\)") :  10.1016/S0140-6736(07)60461-9  .  PMC  "PMC \(identifier\)")  2039891  .  PMID  "PMID \(identifier\)")  17382828  .
63. ** ^  ** Chan R, Hemeryck L, O'Regan M, et al. (May 1995).  "Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial"  . _BMJ_ . **310** (6991): 1360–1362.  doi  "Doi \(identifier\)") :  10.1136/bmj.310.6991.1360  .  PMC  "PMC \(identifier\)")  2549744  .  PMID  "PMID \(identifier\)")  7787537  .
64. ** ^  ** Fukase K, Kato M, Kikuchi S, et al. (August 2008). "Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial". _Lancet_ . **372** (9636): 392–397.  doi  "Doi \(identifier\)") :  10.1016/S0140-6736(08)61159-9  .  hdl  "Hdl \(identifier\)") :   2115/34681  .  PMID  "PMID \(identifier\)")  18675689  .  S2CID  "S2CID \(identifier\)")  13741892  .
65. ** ^  **  Noseworthy JH  , Ebers GC, Vandervoort MK, et al. (January 1994).  "The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial"  . _Neurology_ . **44** (1): 16–20.  doi  "Doi \(identifier\)") :  10.1212/wnl.44.1.16  .  PMID  "PMID \(identifier\)")  8290055  .  S2CID  "S2CID \(identifier\)")  2663997  . Archived from  the original  on 2005-05-10  . Retrieved  2010-03-25  .
66. ** ^  ** Manns MP, McHutchison JG, Gordon SC, et al. (September 2001). "Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial". _Lancet_ . **358** (9286): 958–965.  doi  "Doi \(identifier\)") :  10.1016/S0140-6736(01)06102-5  .  PMID  "PMID \(identifier\)")  11583749  .  S2CID  "S2CID \(identifier\)")  14583372  .
67. ** ^  ** Schwartz GG, Olsson AG, Ezekowitz MD, et al. (April 2001).  "Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial"  . _JAMA_ . **285** (13): 1711–1718.  doi  "Doi \(identifier\)") :   10.1001/jama.285.13.1711  .  PMID  "PMID \(identifier\)")  11277825  .
68. ^  _**a** _ _**b** _ Rossouw JE, Anderson GL, Prentice RL, et al. (July 2002).  "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial"  . _JAMA_ . **288** (3): 321–333.  doi  "Doi \(identifier\)") :   10.1001/jama.288.3.321  .  PMID  "PMID \(identifier\)")  12117397  .  S2CID  "S2CID \(identifier\)")  20149703  .
69. ** ^  ** Hollis S, Campbell F (September 1999).  "What is meant by intention to treat analysis? Survey of published randomised controlled trials"  . _BMJ_ . **319** (7211): 670–674.  doi  "Doi \(identifier\)") :  10.1136/bmj.319.7211.670  .  PMC  "PMC \(identifier\)")  28218  .  PMID  "PMID \(identifier\)")  10480822  .
70. ** ^  ** CONSORT Group.  "Welcome to the CONSORT statement Website"  . Archived from  the original  on 2019-05-09  . Retrieved  2010-03-29  .
71. ** ^  ** Campbell MK, Piaggio G, Elbourne DR, et al. (September 2012).  "Consort 2010 statement: extension to cluster randomised trials"  . _BMJ_ . **345** : e5661.  doi  "Doi \(identifier\)") :   10.1136/bmj.e5661  .  hdl  "Hdl \(identifier\)") :   2164/2742  .  PMID  "PMID \(identifier\)")  22951546  .
72. ** ^  ** Boutron I, Moher D, Altman DG, et al. (February 2008).  "Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration"  . _Annals of Internal Medicine_ . **148** (4): 295–309.  doi  "Doi \(identifier\)") :   10.7326/0003-4819-148-4-200802190-00008  .  PMID  "PMID \(identifier\)")  18283207  .
73. ** ^  ** Boutron I, Moher D, Altman DG, et al. (February 2008).  "Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments"  . _Annals of Internal Medicine_ . **148** (4): W60–W66.  doi  "Doi \(identifier\)") :   10.7326/0003-4819-148-4-200802190-00008-w1  .  PMID  "PMID \(identifier\)")  18283201  .
74. ^  _**a** _ _**b** _ Benson K, Hartz AJ (June 2000).  "A comparison of observational studies and randomized, controlled trials"  . _The New England Journal of Medicine_ . **342** (25): 1878–1886.  doi  "Doi \(identifier\)") :   10.1056/NEJM200006223422506  .  PMID  "PMID \(identifier\)")  10861324  .
75. ^  _**a** _ _**b** _ Concato J, Shah N, Horwitz RI (June 2000).  "Randomized, controlled trials, observational studies, and the hierarchy of research designs"  . _The New England Journal of Medicine_ . **342** (25): 1887–1892.  doi  "Doi \(identifier\)") :  10.1056/NEJM200006223422507  .  PMC  "PMC \(identifier\)")  1557642  .  PMID  "PMID \(identifier\)")  10861325  .
76. ** ^  ** Ioannidis JP, Haidich AB, Pappa M, et al. (August 2001). "Comparison of evidence of treatment effects in randomized and nonrandomized studies". _JAMA_ . **286** (7): 821–830.  CiteSeerX  "CiteSeerX \(identifier\)")  10.1.1.590.2854  .  doi  "Doi \(identifier\)") :  10.1001/jama.286.7.821  .  PMID  "PMID \(identifier\)")  11497536  .
77. ^  _**a** _ _**b** _ Toews I, Anglemyer A, Nyirenda JL, et al. (2024-01-04). "Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study". _The Cochrane Database of Systematic Reviews_ . **1** (1): MR000034.  doi  "Doi \(identifier\)") :  10.1002/14651858.MR000034.pub3  .  ISSN  "ISSN \(identifier\)")  1469-493X  .  PMC  "PMC \(identifier\)") 10765475\.  PMID  "PMID \(identifier\)")  38174786  .
78. ** ^  ** Vandenbroucke JP (March 2008).  "Observational research, randomised trials, and two views of medical science"  . _PLOS Medicine_ . **5** (3): e67.  doi  "Doi \(identifier\)") :   10.1371/journal.pmed.0050067  .  PMC  "PMC \(identifier\)")  2265762  .  PMID  "PMID \(identifier\)")  18336067  .
79. ^  _**a** _ _**b** _ _**c** _ _**d** _ Black N (May 1996).  "Why we need observational studies to evaluate the effectiveness of health care"  . _BMJ_ . **312** (7040): 1215–1218.  doi  "Doi \(identifier\)") :  10.1136/bmj.312.7040.1215  .  PMC  "PMC \(identifier\)")  2350940  .  PMID  "PMID \(identifier\)")  8634569  .
80. ^  _**a** _ _**b** _ Glasziou P, Chalmers I, Rawlins M, et al. (February 2007).  "When are randomised trials unnecessary? Picking signal from noise"  . _BMJ_ . **334** (7589): 349–351.  doi  "Doi \(identifier\)") :  10.1136/bmj.39070.527986.68  .  PMC  "PMC \(identifier\)")  1800999  .  PMID  "PMID \(identifier\)")  17303884  .
81. ** ^  **  Einhorn LH  (April 2002).  "Curing metastatic testicular cancer"  . _Proceedings of the National Academy of Sciences of the United States of America_ . **99** (7): 4592–4595.  doi  "Doi \(identifier\)") :   10.1073/pnas.072067999  .  PMC  "PMC \(identifier\)")  123692  .  PMID  "PMID \(identifier\)")  11904381  .
82. ** ^  ** Wittes J (2002).  "Sample size calculations for randomized controlled trials"  . _Epidemiologic Reviews_ . **24** (1): 39–53.  doi  "Doi \(identifier\)") :   10.1093/epirev/24.1.39  .  PMID  "PMID \(identifier\)")  12119854  .
83. ** ^  ** Freiman JA, Chalmers TC, Smith H, et al. (September 1978). "The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials". _The New England Journal of Medicine_ . **299** (13): 690–694.  doi  "Doi \(identifier\)") :  10.1056/NEJM197809282991304  .  PMID  "PMID \(identifier\)")  355881  .
84. ** ^  ** Charles P, Giraudeau B, Dechartres A, et al. (May 2009).  "Reporting of sample size calculation in randomised controlled trials: review"  . _BMJ_ . **338** : b1732.  doi  "Doi \(identifier\)") :   10.1136/bmj.b1732  .  PMC  "PMC \(identifier\)")  2680945  .  PMID  "PMID \(identifier\)")  19435763  .
85. ** ^  ** Harris R (22 Dec 2018).  "Researchers Show Parachutes Don't Work, But There's A Catch"  . _NPR_ .  Archived  from the original on Jan 17, 2024.
86. ** ^  ** National Health and Medical Research Council (1998-11-16).  _A guide to the development, implementation and evaluation of clinical practice guidelines_  (PDF)  . Canberra: Commonwealth of Australia. p. 56.  ISBN  "ISBN \(identifier\)")  978-1-86496-048-8   . Archived from  the original  (PDF)  on 2017-10-14  . Retrieved  2010-03-28  .
87. ^  _**a** _ _**b** _ Harris RP, Helfand M, Woolf SH, et al. (Methods Work Group; Third US Preventive Services Task Force) (April 2001). "Current methods of the US Preventive Services Task Force: a review of the process". _American Journal of Preventive Medicine_ . **20** (3 Suppl): 21–35.  doi  "Doi \(identifier\)") :  10.1016/S0749-3797(01)00261-6  .  PMID  "PMID \(identifier\)")  11306229  .
88. ** ^  ** Guyatt GH, Oxman AD, Kunz R, et al. (GRADE Working Group) (May 2008).  "What is "quality of evidence" and why is it important to clinicians?"  . _BMJ_ . **336** (7651): 995–998.  doi  "Doi \(identifier\)") :  10.1136/bmj.39490.551019.BE  .  PMC  "PMC \(identifier\)")  2364804  .  PMID  "PMID \(identifier\)")  18456631  .
89. ** ^  ** Oxford Centre for Evidence-based Medicine (2011-09-16).  "Levels of evidence"  . Retrieved  2012-02-15  .
90. ^  _**a** _ _**b** _ _**c** _ Anderson JL, Pratt CM, Waldo AL, et al. (January 1997). "Impact of the Food and Drug Administration approval of flecainide and encainide on coronary artery disease mortality: putting "Deadly Medicine" to the test". _The American Journal of Cardiology_ . **79** (1): 43–47.  doi  "Doi \(identifier\)") :  10.1016/S0002-9149(96)00673-X  .  PMID  "PMID \(identifier\)")  9024734  .
91. ^  _**a** _ _**b** _ Rubin R (2006-10-16).  "In medicine, evidence can be confusing - deluged with studies, doctors try to sort out what works, what doesn't"  . _USA Today_ . Retrieved  2010-03-22  .
92. ** ^  ** Cardiac Arrhythmia Suppression Trial (CAST) Investigators (August 1989). "Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction". _The New England Journal of Medicine_ . **321** (6): 406–412.  doi  "Doi \(identifier\)") :  10.1056/NEJM198908103210629  .  PMID  "PMID \(identifier\)")  2473403  .
93. ** ^  ** Anderson GL, Limacher M, Assaf AR, et al. (April 2004).  "Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial"  . _JAMA_ . **291** (14): 1701–1712.  doi  "Doi \(identifier\)") :   10.1001/jama.291.14.1701  .  PMID  "PMID \(identifier\)")  15082697  .
94. ** ^  ** Grodstein F, Clarkson TB, Manson JE (February 2003). "Understanding the divergent data on postmenopausal hormone therapy". _The New England Journal of Medicine_ . **348** (7): 645–650.  doi  "Doi \(identifier\)") :  10.1056/NEJMsb022365  .  PMID  "PMID \(identifier\)")  12584376  .
95. ** ^  ** Vandenbroucke JP (April 2009). "The HRT controversy: observational studies and RCTs fall in line". _Lancet_ . **373** (9671): 1233–1235.  doi  "Doi \(identifier\)") :  10.1016/S0140-6736(09)60708-X  .  PMID  "PMID \(identifier\)")  19362661  .  S2CID  "S2CID \(identifier\)")  44991220  .
96. ** ^  ** Hsu A, Card A, Lin SX, et al. (December 2009).  "Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk"  . _American Journal of Public Health_ . **99** (12): 2184–2187.  doi  "Doi \(identifier\)") :  10.2105/AJPH.2009.159889  .  PMC  "PMC \(identifier\)")  2775780  .  PMID  "PMID \(identifier\)")  19833984  .
97. ** ^  ** Bell SH, Peck LR (2012).  "Obstacles to and limitations of social experiments: 15 false alarms"  . _Abt Thought Leadership Paper Series_ .
98. ^  _**a** _ _**b** _ _**c** _ Sanson-Fisher RW, Bonevski B, Green LW, et al. (August 2007). "Limitations of the randomized controlled trial in evaluating population-based health interventions". _American Journal of Preventive Medicine_ . **33** (2): 155–161.  doi  "Doi \(identifier\)") :  10.1016/j.amepre.2007.04.007  .  PMID  "PMID \(identifier\)")  17673104  .
99. ^  _**a** _ _**b** _ Johnston SC, Rootenberg JD, Katrak S, et al. (April 2006). "Effect of a US National Institutes of Health programme of clinical trials on public health and costs". _Lancet_ . **367** (9519): 1319–1327.  doi  "Doi \(identifier\)") :  10.1016/S0140-6736(06)68578-4  .  PMID  "PMID \(identifier\)")  16631910  .  S2CID  "S2CID \(identifier\)")  41035177  .
100. ^  _**a** _ _**b** _ Yitschaky O, Yitschaky M, Zadik Y (May 2011).  "Case report on trial: Do you, Doctor, swear to tell the truth, the whole truth and nothing but the truth?"  . _Journal of Medical Case Reports_ . **5** (1): 179.  doi  "Doi \(identifier\)") :   10.1186/1752-1947-5-179  .  PMC  "PMC \(identifier\)")  3113995  .  PMID  "PMID \(identifier\)")  21569508  .
101. ** ^  **  "How Well Do Meta-Analyses Disclose Conflicts of Interests in Underlying Research Studies | The Cochrane Collaboration"  . Cochrane.org. Archived from  the original  on 2014-12-16  . Retrieved  2011-08-19  .
102. ** ^  ** Bekelman JE, Li Y, Gross CP (2003). "Scope and impact of financial conflicts of interest in biomedical research: a systematic review". _JAMA_ . **289** (4): 454–465.  doi  "Doi \(identifier\)") :  10.1001/jama.289.4.454  .  PMID  "PMID \(identifier\)")  12533125  .
103. ^  _**a** _ _**b** _ Bhandari M, Busse JW, Jackowski D, et al. (February 2004).  "Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials"  . _CMAJ_ . **170** (4): 477–480.  PMC  "PMC \(identifier\)")  332713  .  PMID  "PMID \(identifier\)")  14970094  .
104. ** ^  ** Chapman SJ, Shelton B, Mahmood H, et al. (December 2014).  "Discontinuation and non-publication of surgical randomised controlled trials: observational study"  . _BMJ_ . **349** : g6870.  doi  "Doi \(identifier\)") :  10.1136/bmj.g6870  .  PMC  "PMC \(identifier\)")  4260649  .  PMID  "PMID \(identifier\)")  25491195  .
105. ** ^  ** Ridker PM, Torres J (May 2006).  "Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005"  . _JAMA_ . **295** (19): 2270–2274.  doi  "Doi \(identifier\)") :   10.1001/jama.295.19.2270  .  PMID  "PMID \(identifier\)")  16705108  .
106. ** ^  ** Zhang S, Cao J, Ahn C (August 2010).  "Calculating sample size in trials using historical controls"  . _Clinical Trials_ . **7** (4): 343–353.  doi  "Doi \(identifier\)") :  10.1177/1740774510373629  .  PMC  "PMC \(identifier\)")  3085081  .  PMID  "PMID \(identifier\)")  20573638  .
107. ** ^  ** Deaton A, Cartwright N (August 2018).  "Understanding and misunderstanding randomized controlled trials"  . _Social Science & Medicine _ . Randomized Controlled Trials and Evidence-based Policy: A Multidisciplinary Dialogue. **210** : 2–21.  doi  "Doi \(identifier\)") :  10.1016/j.socscimed.2017.12.005  .  PMC  "PMC \(identifier\)")  6019115  .  PMID  "PMID \(identifier\)")  29331519  .
108. ** ^  ** Rowland D, DiGuiseppi C, Gross M, et al. (January 2003).  "Randomised controlled trial of site specific advice on school travel patterns"  . _Archives of Disease in Childhood_ . **88** (1): 8–11.  doi  "Doi \(identifier\)") :  10.1136/adc.88.1.8  .  PMC  "PMC \(identifier\)")  1719287  .  PMID  "PMID \(identifier\)")  12495948  .
109. ** ^  ** Graham-Rowe E, Skippon S, Gardner B, et al. (2011). "Can we reduce car use and, if so, how? A review of available evidence". _Transportation Research Part A: Policy and Practice_ . **44** (5): 401–418.  doi  "Doi \(identifier\)") :  10.1016/j.tra.2011.02.001  .
110. ** ^  ** Melia S (2011).  "Do Randomised Control Trials Offer a Solution to 'low Quality' Transport Research?'  "  . _Transportation Research Part A_ . Bristol: University of the West of England.
111. ^  _**a** _ _**b** _ Farrington DP, Welsh BC (2005). "Randomized experiments in criminology: What have we learned in the last two decades?". _ Journal of Experimental Criminology  _ . **1** (1): 9–38.  doi  "Doi \(identifier\)") :  10.1007/s11292-004-6460-0  .  S2CID  "S2CID \(identifier\)")  145758503  .
112. ** ^  ** Hollin CR (2008). "Evaluating offending behaviour programmes: does only randomization glister?". _ Criminology and Criminal Justice  _ . **8** (1): 89–106.  doi  "Doi \(identifier\)") :  10.1177/1748895807085871  .  S2CID  "S2CID \(identifier\)")  141222135  .
113. ** ^  ** Connolly P, Keenan C, Urbanska K (2018-07-09).  "The trials of evidence-based practice in education: a systematic review of randomised controlled trials in education research 1980–2016" .html) . _Educational Research_ . **60** (3): 276–291.  doi  "Doi \(identifier\)") :   10.1080/00131881.2018.1493353  .  ISSN  "ISSN \(identifier\)")  0013-1881  .
114. ** ^  ** Walker HM, Seeley JR, Small J, et al. (2009). "A randomized controlled trial of the First Step to Success early intervention. Demonstration of program efficacy outcomes in a diverse, urban school district". _ Journal of Emotional and Behavioral Disorders  _ . **17** (4): 197–212.  doi  "Doi \(identifier\)") :  10.1177/1063426609341645  .  S2CID  "S2CID \(identifier\)")  144571336  .
115. ** ^  ** Bradshaw CP, Zmuda JH, Kellam SG, et al. (November 2009).  "Longitudinal Impact of Two Universal Preventive Interventions in First Grade on Educational Outcomes in High School"  . _Journal of Educational Psychology_ . **101** (4): 926–937.  doi  "Doi \(identifier\)") :  10.1037/a0016586  .  PMC  "PMC \(identifier\)")  3678772  .  PMID  "PMID \(identifier\)")  23766545  .
116. ** ^  ** Krauss A (June 2018).  "Why all randomised controlled trials produce biased results"  . _Annals of Medicine_ . **50** (4): 312–322.  doi  "Doi \(identifier\)") :   10.1080/07853890.2018.1453233  .  PMID  "PMID \(identifier\)")  29616838  .